Inovio Pharmaceuticals has been granted a patent for an electroporation device with a needle array that includes an adjustable auto-lock assembly. The device allows for precise control over the movement of the needle array, enhancing the efficiency and effectiveness of electroporation procedures. GlobalData’s report on Inovio Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inovio Pharmaceuticals, Personalized cancer vaccines was a key innovation area identified from patents. Inovio Pharmaceuticals's grant share as of February 2024 was 40%. Grant share is based on the ratio of number of grants to total number of patents.
Electroporation device with adjustable needle array auto-lock assembly
A recently granted patent (Publication Number: US11883653B2) discloses a needle array for an electroporation device. The device includes a body with a locking surface, a shroud that can move between rest and actuated positions, and an auto-lock mechanism that allows for locking and unlocking configurations. The auto-lock, which is adjustable by biasing the shroud, engages the locking surface to secure the shroud in place. Additionally, the body may have electrodes or hypodermic needles attached, with the electrodes extending outside the shroud in the actuated positions and the needles positioned within the shroud in the rest position.
Furthermore, the needle array may include a receiver for a drug cartridge, with a hypodermic needle extending from the receiver for fluid communication with the cartridge. A drive assembly with an injection rod is also part of the device, allowing for the injection of the drug into a patient. The receiver can be locked in place with a locking pin that moves between locked and unlocked positions based on its alignment with a locking aperture. Additionally, a cartridge lock feature permits the insertion of the drug cartridge into the receiver but prevents its removal, ensuring safe and secure drug delivery. Overall, the patented needle array design offers a versatile and secure solution for electroporation procedures and drug delivery applications.
To know more about GlobalData’s detailed insights on Inovio Pharmaceuticals, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
